Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

ASH 2017: Targeted antibody mogamulizumab superior to vorinostat for previously treated CTCL in phase III trial

ASH 2017: Targeted antibody mogamulizumab superior to vorinostat for previously treated CTCL in phase III trial

ASH 2017: Addition of targeted drug reduces risk of first-line treatment failure in advanced Hodgkin lymphoma

ASH 2017: Addition of targeted drug reduces risk of first-line treatment failure in advanced Hodgkin lymphoma

ASH 2017: Combination treatment with two targeted agents shows promise in previously treated CLL

ASH 2017: Combination treatment with two targeted agents shows promise in previously treated CLL

ASH 2017: Rapid responses, few adverse effects seen with targeted agent in Phase I trial in rare blood disorder

ASH 2017: Rapid responses, few adverse effects seen with targeted agent in Phase I trial in rare blood disorder

For leukaemia patients, transfusion needs may delay hospice care

For leukaemia patients, transfusion needs may delay hospice care

ASH 2017: Sustained benefit with Ibrutinib in r/r MCL

ASH 2017: Sustained benefit with Ibrutinib in r/r MCL

ASH 2017: Direct oral anticoagulant reduces recurrence of harmful clots in patients with cancer

ASH 2017: Direct oral anticoagulant reduces recurrence of harmful clots in patients with cancer

Novel harvesting method rapidly produces superior stem cells for transplantation

Novel harvesting method rapidly produces superior stem cells for transplantation

Genetic link found between the immune system and lymphoma

Genetic link found between the immune system and lymphoma

Immune-boosting antibody combination could improve lymphoma survival

Immune-boosting antibody combination could improve lymphoma survival

More from ecancer